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Abstract. 
 
Endothelial cells (EC) express several mem-
bers of the Homeobox (Hox) gene family, suggesting a 
role for these morphoregulatory mediators during an-
giogenesis. We have previously established that Hox D3 
is required for expression of integrin 
 
a
 
v
 
b
 
3 and uroki-
nase plasminogen activator (uPA), which contribute to 
EC adhesion, invasion, and migration during angiogen-
esis. We now report that the paralogous gene, Hox B3, 
inﬂuences angiogenic behavior in a manner that is dis-
tinct from Hox D3. Antisense against Hox B3 impaired 
capillary morphogenesis of dermal microvascular EC 
cultured on basement membrane extracellular matrices. 
Although levels of Hox D3-dependent genes were 
maintained in these cells, levels of the ephrin A1 ligand 
were markedly attenuated. Capillary morphogenesis 
could be restored, however, by addition of recombinant 
ephrin A1/Fc fusion proteins. To test the impact of Hox 
B3 on angiogenesis in vivo, we constitutively expressed 
Hox B3 in the chick chorioallantoic membrane using 
avian retroviruses that resulted in an increase in vascu-
lar density and angiogenesis. Thus, while Hox D3 pro-
motes the invasive or migratory behavior of EC, Hox 
B3 is required for the subsequent capillary morphogen-
esis of these new vascular sprouts and, together, these 
results support the hypothesis that paralogous Hox 
genes perform complementary functions within a par-
ticular tissue type.
Key words: endothelial cells • Hox • neovasculariza-
tion • extracellular matrix • ephrin
 
Introduction
 
The Homeobox (Hox)
 
1
 
 morphoregulatory genes encode
transcription factors that play an essential role in organo-
genesis during development and, more recently, have been
linked to both hormonal and pathologically induced tissue
remodeling in adults (for review Boudreau and Bissell,
1998; Stelnicki et al., 1998; Chen and Capecchi, 1999; for
review Cillo et al., 1999). Although the identity of many
genes whose expression is modulated by binding of Hox
proteins to target DNA sequences remains to be firmly
established, a growing body of evidence indicates that
genes associated with cell–cell and cell–extracellular ma-
trix (ECM) interactions are putative targets of Hox activ-
ity (Jones et al., 1992; Li and Gudas, 1996; Boudreau et al.,
1997; Lorentz et al., 1997).
To this end, we have been investigating a potential role
for homeobox genes during angiogenesis, a process which
involves extensive, coordinated changes in cell–cell and
cell–ECM interactions. In response to angiogenic stimula-
tors, including the tumor or wound microenvironment,
normally quiescent endothelial cells (EC) upregulate ex-
pression of proteinases, including matrix metalloprotein-
ases and urokinase plasminogen activator (uPA), which
degrade the surrounding basement membrane (BM) ECM
(for review see Werb et al., 1999). As EC reenter the cell
cycle, they also upregulate expression of adhesion mole-
cules, including 
 
a
 
v
 
b
 
3 integrin, which allows the cells to ad-
here and migrate into the adjacent stromal matrix environ-
ment (Brooks et al., 1994). After this, EC must then
resynthesize and deposit a new BM ECM and undergo
morphological reorganization into tubular structures com-
plete with a lumen (Stromblad and Cheresh, 1996). Matu-
ration of the newly formed capillaries follows via recruit-
ment of pericytes, which strengthen and stabilize the
vascular wall (Hirschi and D’Amore, 1996; Maisonpierre
et al., 1997).
We previously identified several class I Homeobox
genes expressed in cultured EC and showed that one of
these, namely Hox D3, is required for expression of the 
 
b
 
3
subunit of the 
 
a
 
v
 
b
 
3 integrin, as well as for expression of
the uPA. When constitutively expressed in EC
 
 
 
in vivo,
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Hox D3 produced endothelioma-like structures, consistent
with a role for this gene in mediating the invasive and mi-
gratory behavior of EC during the early stages of neovas-
cularization (Boudreau et al., 1997). Recent work by oth-
ers has also shown that EC upregulate the expression of
several members of the Hox B cluster or splice variants of
Hox A9 in response to a variety of angiogenic cytokines
(Belotti et al., 1998; Patel et al., 1999). The role of these
genes during angiogenesis, however, remains to be estab-
lished. Given the complex multistep nature of angiogene-
sis and the coordinate changes in cell–cell and cell–ECM
interactions, it is likely that many of the Hox genes ex-
pressed in EC contribute to this process. Having estab-
lished a role for Hox D3 during the early stages of angio-
genesis, we are particularly interested in establishing a role
for Hox genes that may act at later stages of angiogenesis,
which involve resynthesis of BM ECM and/or acquisition
of a tubular three-dimensional capillary morphology.
Evidence gathered from single and compound Hox null
mice have suggested that paralogous Hox genes (i.e., those
with similar numerical designations, but located on dif-
ferent chromosomes such as Hox D3, Hox B3, and Hox
A3) may play complementary, overlapping, or synergistic
roles in a particular tissue (Condie and Capecchi, 1994;
Manley and Capecchi, 1997). For example, whereas dele-
tion of a single member of Hox 9 paralogous group did not
significantly impact postnatal mammary gland develop-
ment, deletion of Hox A9, B9, and D9 dramatically im-
paired the normal branching morphogenesis and dif-
ferentiation of this tissue (Chen and Capecchi, 1999).
Therefore, we wished to investigate whether paralogues of
Hox D3 also contribute to angiogenic behavior in EC and
whether these genes acted at the same or later stages of
neovascularization. We had previously observed that the
paralogous gene Hox B3 is highly expressed in adult EC
(Boudreau et al., 1997) and thus wished to establish
whether this gene acted in concert with Hox D3 and/or via
distinct mechanisms to influence endothelial cell behavior.
 
Materials and Methods
 
Cells, Culture Conditions, and Cytokines
 
An immortalized human dermal microvascular endothelial cell line
(HMEC-1; Ades et al., 1992), was a gift from T. Lawley (Emory Univer-
sity, Atlanta, GA). These cells previously have been shown to maintain
many properties of primary dermal microvascular cells in culture, includ-
ing the ability to undergo capillary morphogenesis when cultured on BM
(Matrigel) and maintain expression of a number of endothelial cell surface
markers (Xu et al., 1994). Cells were maintained in media MCBD 131 sup-
plemented with 10% FCS, gentimicin, and 1% hydrocortisone (Sigma
Chemical Co.) and passaged using calcium- and magnesium-free PBS sup-
plemented with 0.053 mM EDTA. Primary cultures of HMEC were pur-
chased from Clonetics. Recombinant mouse ephrin A1/human IgG fusion
proteins, recombinant human VEGF, and basic fibroblast growth factor
(bFGF) were purchased from R&D Systems. Recombinant human TNF 
 
a
 
and Matrigel were obtained from Collaborative Research. Endothelial
cell culture on BM (Matrigel) was performed as previously described
(Boudreau et al., 1997). To release cells from Matrigel for protein or
mRNA determination, cultures were suspended in PBS without Ca
 
2
 
1
 
 or
Mg
 
2
 
1
 
, containing 0.5 mM EDTA and incubated on ice for 1 h to allow the
Matrigel to disperse. Cells were then pelleted by centrifugation at 500 
 
g
 
for 5 min at 4
 
8
 
C. For the ephrin add back experiments, 250 ng/ml recombi-
nant mouse ephrin A1 fused to human IgG was diluted in serum-free
MCDB 131 and preclustered for 1 h at room temperature using 25 ng/ml
of an antibody against the Fc region of human IgG (Sigma Chemical Co.)
 
as described (Wang and Anderson, 1997). Clustered ephrins were added
to cells at the time of plating on Matrigel.
 
RNA Isolation and Northern Blot Analysis
 
Total RNA was isolated from HMEC-1 using the Qiagen RNEasy kit. For
Northern blot analysis, a total of 10 or 20 
 
m
 
g total RNA was electropho-
resed through 1% agarose formaldehyde gels as previously described using
standard methods (Boudreau et al., 1997). Ribosomal RNA was visual-
ized by staining with 1% ethidium bromide. 
 
32
 
P{dCTP} probes were pre-
pared using the Ambion Decaprime Kit and purified using Sephadex G-25
columns (Boehringer Mannheim Corp.). Blots were probed with 1 
 
3
 
 10
 
6
 
cpm/ml of hybridization buffer (Hybridsol I; Oncor) and exposed to
Kodak M5 X-Omat film at 
 
2
 
70
 
8
 
C. cDNA for integrin 
 
b
 
3 was a gift from
David Cheresh (The Scripps Research Institute, La Jolla, CA).
 
Reverse Transcriptase PCR Measurement of Hox B3
in EC
 
1 
 
m
 
g of total RNA was reverse transcribed using MMuLV RT for 1 h in
total volume of 25 
 
m
 
l. 0.1, 1, 2, and 10 
 
m
 
l of this RT reaction was then am-
plified for 20, 30, or 35 cycles of 95, 58, and 72
 
8
 
C for 30, 30, and 90 s, re-
spectively, with the following primers: forward primer 5
 
9
 
 cgatgcagaaagc-
cacctactacgac 3
 
9
 
 corresponding to bp 362–387 of human Hox B3, and
reverse primer 5
 
9
 
 cgccgaccccggggggctcttct 3
 
9
 
 corresponding to nucleotides
1,666–1,682 of the published sequence. The expected 1.32-kb PCR prod-
uct was visualized by electrophoresis on 1% agarose gels containing ethid-
ium bromide. From this analysis, it was determined that amplification of 1
 
m
 
l of the total 25 
 
m
 
l RT reaction for 30 cycles gave optimal, reproducible
results within the linear range for amplification. To normalize for total
RNA, 1 
 
m
 
l of the same RT reaction was diluted 1:800 in water and ampli-
fied under the same conditions with commercially available primer sets
for human GAPDH or 
 
b
 
-actin (Stratagene). The 1.32-kb PCR product
corresponding to Hox B3 was subsequently ligated into the TOPO II TA
cloning vector (Invitrogen Corp.) and the identity confirmed as Hox B3
by dideoxy sequencing using the USB Sequenase 2 kit (Nycomed Amer-
sham, Inc.).
 
Construction of Hox B3 Sense and Antisense 
Expression Vectors
 
The insert containing the entire cDNA encoding human Hox B3 was sub-
cloned into the expression vector PCR 3.1 containing a CMV promoter
(Invitrogen Corp.). The orientation was confirmed by restriction digest
and the ends were resequenced to confirm the identity and orientation.
Clones in the antisense orientation were directly transfected into HMEC-1
using a CaP0
 
4
 
 method and stable transfectants selected in the presence
of 50 
 
m
 
g/ml G418. To achieve high levels of translation and expression of
Hox B3 in the sense orientation, we introduced a Kozak consensus se-
quence on the 5
 
9
 
 end by reamplifying the cDNA with the primer 5
 
9
 
 ggaat-
tcggccaccatgcaga 3
 
9
 
. The resulting cDNA was religated into the same PCR
3.1 expression in the sense orientation, stably transfected into HMEC-1,
and stable pools were selected as described above. To allow us to distin-
guish transgene expression from endogenous Hox B3, we have also added
a COOH-terminal 6
 
3
 
His epitope tag by deleting the stop codon and clon-
ing into the PCR 3.1 mycHis vector (Invitrogen Corp.). This construct was
subsequently cloned into the CK proviral vector described below.
 
Western Blotting
 
Total protein was isolated from EC using ice-cold 10 mM Tris/150 mM
NaCl in the presence of 10 
 
m
 
g/ml aprotinin, pepstatin, and leupeptin, and
0.02 M PMSF. Protein concentration was determined using a protein assay
kit (BioRad). For Western analysis, a total of 20 or 50 
 
m
 
g protein lysates
were run on SDS-PAGE and transferred to PVDF membranes (Immo-
bilon; Nycomed Amersham Inc.). Membranes were blocked in 5% milk
protein in 10 mM TBS, pH
 
 
 
7.6. Polyclonal antibodies against Hox B3 were
purchased from Berkeley Antibody Co. Polyclonal rabbit anti–human an-
tibodies against ephrin A1 were purchased from Santa Cruz Biotechnol-
ogy (sc-911). For Western Blot analysis, a 1:2,000 or 1:500 dilution was
used as indicated, followed by incubation with HRP-conjugated goat anti–
rabbit antibodies (Nycomed Amersham Inc.). To reduce nonspecific
background, blots were washed in 1 M NaCl followed by several washes in
TBS, pH
 
 
 
7.6. Bands were visualized by enhanced chemiluminescence
(ECL Plus; Nycomed Amersham Inc.). 
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cDNA Probes for Ephrin A1 and Ephrin B1
 
A cDNA probe corresponding to ephrin A1 was isolated using the follow-
ing primer pairs: forward 5
 
9
 
 ggaacccagacccataggagac 3
 
99 
 
corresponding to
nucleotides 17–38, and the reverse primer 5
 
9 
 
ttcagcctgtccctctttaaga 3
 
9
 
 cor-
responding to nucleotides 711–732 of the human sequence (GenBank/
EMBL/DDBJ accession numbers M57730 and M37476). The resulting
0.7-kb PCR product was ligated into the TOPO cloning vector and the
identity confirmed by sequencing as described. The entire 700-bp insert
was used for Northern blot analysis. A probe for ephrin B1 was also gen-
erated by RT-PCR from 1 
 
m
 
g total RNA for 30 cycles at 95,
 
 
 
58, and 72
 
8
 
C
for 30, 30, and 90 s, respectively, using the following primer pairs: forward
5
 
9
 
 ttg gtg agg agg cgc caa gg 3
 
9
 
 corresponding to nucleotides 653–672, and
the reverse primer 5
 
99
 
 ggg cac tca gac ctt gta gta ga 3
 
9
 
 corresponding to nu-
cleotides 1,748–1,726 of the published sequence of human ephrin B1
(GenBank/EMBL/DDBJ accession number NM_004429). The 1,095-bp
PCR product was ligated into the TOPO II PCR cloning vector (Invitro-
gen Corp.) and the identity of the PCR product confirmed as ephrin B1 by
dideoxy sequencing as described above.
 
Immunoprecipitation of Eph A2 Receptor
 
EphA2 receptor was measured by immunoprecipitation of equal amounts
of protein lysates of HMEC-1 using a polyclonal antibody against human
Eph A2 (sc-924; Santa Cruz Biotechnology). HMEC-1 were lysed in ice-
cold 10 mM Tris-HCl/150 mM NaCl, pH
 
 
 
7.6, in the presence of 2 mM NaF,
2 mM orthovanadate, 10 
 
m
 
g/ml aprotinin, pepstatin, and leupeptin, and
0.02 M PMSF. After determination of protein concentrations, 300 
 
m
 
g of
cellular lysate was diluted in RIPA containing 2 mM NaF and 2 mM
orthovanadate, and immune complexes precipitated using 25 
 
m
 
l of a 10%
wt/vol solution of protein A–Sepharose (Sigma Chemical Co.). Pellets
were washed three times in RIPA, followed by two additional washes in
PBS, and resuspended in 2
 
3
 
 Laemmli sample buffer. After separation on
7.5% SDS-PAGE and transfer to PVDF membranes, blots were probed
with antibodies against Eph A2 or antibodies against total phosphoty-
rosine (clone 4G10; Upstate Biotechnology).
 
Migration Assays
 
Endothelial cell migration assays were performed using a modification
of the method described by Klemke et al. (1997). In brief, migration as-
says were performed using tissue culture-treated Transwell chambers of
6.5-mm diam, with 8-
 
m
 
m pores (Costar Corp.). The bottom surfaces of the
chambers were coated with 20 
 
m
 
g/ml of bovine fibrinogen (Sigma Chemi-
cal Co.) or 1% BSA for controls. Before the assay, wells were rinsed twice
with migration buffer (fibroblast basal medium 
 
1 
 
0.5% BSA; Clonetics).
EC were serum-starved for 18 h and removed from the culture dishes by
harvesting with Ca
 
2
 
1
 
-
 
 
 
and
 
 
 
Mg
 
2
 
1
 
-free PBS containing 0.53 mM EDTA, and
resuspended in migration buffer. 50,000 cells were added to each well and
the assay was allowed to proceed for 5 h at 37
 
8
 
C. Nonmigratory cells were
removed from the upper chambers with a cotton swab and cells that had
migrated to the bottom of the membrane were visualized by fixing and
staining with Diff-Quick (VWR Scientific Products). The total number of
cells that had migrated was determined by counting at least five different
fields using a Nikon inverted TMS microscope. Alternatively, quantitative
analysis of migration was performed by measuring absorbance of methy-
lene blue stained cells at 600 nm. Each determination represents the aver-
age of three individual wells and error bars represent SD.
 
Construction and Application of Avian
Replication-defective Retroviruses Expressing Hox B3 
in Chick Chorioallantoic Membrane
 
To produce replication defective retroviruses encoding Hox B3, the
cDNA encoding the entire human Hox B3 sequence was excised with
HindIII and PmeI and inserted into the proviral vector CK at the HindIII
site and an XbaI site that was blunted with Klenow polymerase. The viral
packaging cell line, Q4dh, derived from the QT6 quail fibrosarcoma cells
line (Stoker and Bissell, 1988), was maintained in M199 containing 4%
FCS, 1% chicken serum, and 1
 
3
 
 tryptose phosphate broth. Stable trans-
fectants expressing either human Hox B3 proviral vectors or empty vector
(CK) were performed using CaP0
 
4
 
, and pools of stable transfectants pro-
ducing infectious virus were selected in the presence of 200 
 
m
 
g/ml G418 as
described (Stoker and Bissell, 1988; Boudreau et al., 1997). To induce an-
giogenesis, we grafted 5 
 
3 
 
10
 
6
 
 Q4dh cells in a volume of 50 
 
m
 
l of medium
M199 onto the chick chorioallantoic membranes (CAMs) of 10-day chick
SPAFAS pathogen-free chick embryos as previously described (Boudreau
et al., 1997). After 72 h, CAMs were harvested and vascular density, mor-
phology, and immunohistochemical analysis were performed. Angiogene-
sis was quantitated by counting the number of branch points arising from
the tertiary vessels in a 6-mm square area on the underside of the tumors.
Measurements were made in 12 samples infected with control virus and 12
samples infected with Hox B3 expressing virus from three separate exper-
iments. Statistical significance was assessed using a paired 
 
t
 
 test.
 
Tissue Fixation and Immunofluorescence
 
CAMs were fixed in situ in 4% paraformaldehyde, embedded in OCT me-
dium, and frozen in a dry ice/ethanol bath and stored at 
 
2
 
70
 
8
 
C. 7-
 
m
 
m sec-
tions of the CAMS were used for immunohistochemistry. After brief ace-
tone fixation, sections were air-dried and subsequently blocked in PBS
containing 2% BSA for 1 h, followed by staining with appropriate anti-
bodies. A 1:200 dilution of a monoclonal anti–his-6 antibody (Boehringer
Mannheim Corp.) diluted in PBS containing 0.025% Triton X-100, 0.1%
BSA, or a 1:200 dilution of a polyclonal rabbit anti–human antibody
against von Willebrand factor were used, followed by incubation for 1 h
with FITC-conjugated goat anti–mouse (Cappel Laboratories) or Texas
red-conjugated goat anti–rabbit secondary antibody (Calbiochem-Nova-
biochem Corp.).
 
Results
 
Expression of Hox B3 in Cultured Endothelial Cells
 
As the levels of Hox mRNA and protein expression in
mammalian cells are normally low, we established condi-
tions to measure Hox B3 using semiquantitative RT-PCR.
Using the RT-PCR conditions described in Materials and
Methods, we assessed expression levels of Hox B3 in
both primary human dermal microvascular cells or the
immortalized HMEC-1 cultured under various conditions.
Although EC continue to proliferate and form a cobble-
stone monolayer when plated on untreated tissue culture
dishes, culturing on dishes coated with reconstituted BM
induces EC to become quiescent and adopt a three-dimen-
sional capillary-like morphology (Kubota et al., 1988; Bou-
dreau et al., 1997). Therefore, we compared expression of
Hox B3 in cells cultured in the presence or absence BM
(Fig. 1 A). In contrast to our previous observations show-
ing that BM suppressed expression of Hox D3, we ob-
served that Hox B3 was expressed at slightly higher levels
in HMEC-1 cultured on BM for 24 h, as compared with
cells maintained in the absence of BM (Fig. 1 A). Similar
results were observed in primary cultures of dermal mi-
crovascular EC (not shown). We also treated EC with the
angiogenic cytokine, bFGF, and observed that levels of
Hox B3 were not increased by this treatment (Fig. 1 B).
This distinct expression profile of Hox B3 suggested that,
perhaps, Hox B3 and Hox D3 contributed to different en-
dothelial cell phenotypes.
 
Suppression of Hox B3 Impairs Capillary 
Morphogenesis of EC Cultured on BM ECM
 
Because levels of Hox B3 are maintained when EC are
cultured on BM, we reasoned that Hox B3 may contribute
to the capillary-like morphogenesis that EC undergo when
they are cultured on reconstituted BM. Therefore, we sta-
bly transfected an immortalized line of dermal HMEC-1
with CMV-driven plasmids expressing antisense against
Hox B3 or with empty plasmid (control). Western blot
analysis of stable pools of cells transfected with antisense 
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against Hox B3 displayed a decrease in Hox B3 protein, as
compared with control transfected cells (Fig. 2 A). In con-
trast to controls, we also observed that when cells with re-
duced levels of Hox B3 were cultured on BM ECM, many
formed aggregates and were unable to branch or form cap-
illary-like tubules, indicating that Hox B3 is necessary for
BM-dependent capillary morphogenesis (Fig. 2 B). Fur-
thermore, we also observed that BM-induced capillary
morphogenesis of EC is not influenced by blocking Hox
D3 or its putative target, integrin 
 
a
 
v
 
b
 
3. In addition, we
also observed that blocking either Hox D3 or Hox B3 us-
ing antisense did not influence expression of the paralo-
gous genes (Boudreau et al., 1997; data not shown). To-
gether, these results indicate that the paralogous Hox B3
and Hox D3 genes have distinct effects on EC behavior.
 
Impaired Capillary Morphogenesis in the Absence of 
Hox B3 Correlates with Decreased Levels of Ephrin A1, 
but Not the EphA2 Receptor in EC
 
Although many factors have been reported to influence
capillary morphogenesis in cultured EC, several recent re-
ports have implicated interactions between ephrin ligands
and their corresponding Eph receptors in the morphogen-
esis of EC cultured on BM and during angiogenesis in vivo
(Pandey et al., 1995; Daniel et al., 1996; Adams et al.,
1999). In addition, as Hox genes have been linked to regu-
lation of expression of the EphA2 receptor during devel-
opment, we wished to further explore a potential link be-
tween Hox B3 and ephrin or Eph receptor-expression in
EC (Chen and Ruley, 1998; Studer et al., 1998). We ini-
tially compared the levels of the EphA2 receptor by im-
munoprecipitation of lysates from control transfected
HMEC-1 or HMEC-1 transfected with antisense against
Hox B3 (Fig 3 A). Although the levels of the Eph A2 re-
ceptor were similar, subsequent blotting revealed that
phosphorylation of the EphA2 receptor was dramatically
reduced in cells lacking Hox B3 (Fig. 3 A). These findings
further suggested that the levels of an ephrin ligand that
may bind to and activate phosphorylation of the EphA2
receptor may be reduced in cells lacking Hox B3. There-
fore, we performed a Western blot analysis with antibod-
ies against the ephrin A1 ligand and observed that its ex-
pression was significantly reduced in EC transfected with
antisense against Hox B3 (Fig. 3 A). Furthermore, the re-
duction of ephrin A1 protein and mRNA (Fig. 3, A and B)
appeared to be somewhat selective, since levels of another
ephrin ligand, ephrin B1, were not affected (Fig. 3 B). Im-
portantly, the level of integrin 
 
b
 
3 (Fig. 3 B) and uPA (not
shown), two targets of Hox D3 activity, were unaffected.
These results indicate that paralogous Hox genes have dis-
tinct target genes within a particular tissue type.
 
Capillary Morphogenesis Can Be Enhanced by Addition 
of Ephrin A1 in Cells Expressing Antisense against
Hox B3
 
To determine whether restoring ephrin A1 ligand to EC
lacking Hox B3 could help these cells regain a three-
dimensional
 
 
 
capillary-like
 
 
 
morphology, cells were treated
with preclustered, recombinant mouse ephrin A1/human
Fc fusion proteins. Fig. 4 A shows that addition of clus-
tered mouse ephrin A1/Fc fusion protein was capable of
eliciting high levels of phosphorylation of the human
EphA2 receptor in both control transfected HMEC-1 and
those transfected with antisense against Hox B3. More sig-
nificantly, addition of recombinant ephrin A1/Fc fusion
proteins partially restored the ability of cells lacking Hox
Figure 1. Expression of Hox B3 in HMEC cultured under differ-
ent conditions. A, Semiquantitative RT-PCR of Hox B3 (left) and
GAPDH (right) in HMEC grown in the presence (1) or absence
(2) of BM (Matrigel) shows the relative levels of the 1.3-kb tran-
script encoding Hox B3 in EC under each of these conditions.
The 0.6-kb transcript for GAPDH was used to normalize levels
of RNA used in this analysis. B, Semiquantitative RT-PCR for
Hox B3 in HMEC cultured in the presence or absence bFGF (50
ng/ml) for 24 h.
Figure 2. Antisense against
Hox B3 impairs BM-induced
capillary morphogenesis in
EC. A, Western blot for Hox
B3 in 50 mg total protein ly-
sates from immortalized
HMEC-1 stably transfected
with empty vector (control)
or plasmid expressing anti-
sense against human Hox B3
(Hox B3 AS). B, Capillary
morphogenesis of HMEC-1
after culturing on thick BM
(Matrigel) after 18 h. The
panel on the left shows normal capillary morphogenesis occurring in HMEC-1 stably transfected with empty vector (Control). The
panel on the right shows impaired capillary morphogenesis in HMEC-1 transfected with antisense against Hox B3 (Hox B3 AS). The ar-
row shows representative groups of cells that remain in clusters and fail to elongate and form contacts with adjacent cells. 
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B3 to elongate and form branching networks resembling
the three-dimensional capillary networks produced by un-
treated control transfected cells (Fig. 4 B). This ephrin
A1-enhanced capillary morphogenesis was observed as
early as four hours after plating on reconstituted BMs and
persisted for at least 18 h. Thus, the Hox B3-dependent ex-
pression of ephrin A1 contributes to the normal capillary-
like morphogenesis acquired by EC cultured on reconsti-
tuted BM.
 
Overexpression of Hox B3, but Not Hox D3, Results in 
Increased Levels of Ephrin A1 Expression 
 
To further establish a relationship between Hox B3 and
ephrin A1 expression, we transfected HMEC-1 with vec-
tors containing CMV-driven human Hox B3. Western blot
analysis of stable pools of cells transfected with Hox B3
showed increased levels of Hox B3 protein, as compared
with HMEC-1 transfected with empty vector (control; Fig.
5 A). Cells overexpressing Hox B3 also showed the pre-
dicted increase in expression of ephrin A1 protein (Fig. 5
A). Immunoprecipitation with an anti-EphA2 antibody of
lysates from HMEC-1 transfected with Hox B3 plasmid or
empty vectors indicated that, although levels of the EphA2
receptor were not increased, subsequent blotting with an-
tiphosphotyrosine antibodies revealed an increased level
of phosphorylation of the receptor in cells overexpressing
Hox B3 and ephrin A1 ligand (Fig. 5 B). HMEC-1 overex-
pressing Hox B3 also show the expected increase in ephrin
A1 mRNA levels (Fig. 5 C), whereas HMEC-1 transfected
with the paralogous gene Hox D3 do not upregulate ex-
pression of ephrin A1, but do show increased expression
of 
 
b
 
3 integrin mRNA (Fig. 5 D). Furthermore, we directly
compared the ability of EC overexpressing Hox B3 or Hox
D3 to migrate into a fibrinogen-rich environment. We ob-
served that, whereas the Hox B3 transfected cells migrated
at a rate similar to control transfected cells, Hox D3 trans-
fected EC that express high levels of integrin 
 
a
 
v
 
b
 
3, show a
significantly enhanced ability to migrate in this environ-
ment (Fig. 5 E). These results again emphasize that Hox
B3 and Hox D3 specifically modulate expression of differ-
ent angiogenic effector molecules in cultured EC, which in
turn, contribute to different aspects of the angiogenic pro-
cess.
Figure 3. Expression of ephrin A1 is selectively reduced in EC
lacking Hox B3. A, The upper panel shows similar amounts of a
120-kD band corresponding to EphA2 recovered by immunopre-
cipitation from control transfected (Control) HMEC-1 and
HMEC-1 transfected with antisense against Hox B3 (AS). The
middle panel shows subsequent blotting with an antiphosphoty-
rosine antibody and reveals a reduced level of phosphorylation of
the EphA2 receptor in cells transfected with antisense against
Hox B3. The lower panel shows Western blotting with a poly-
clonal antibody against ephrin A1 (1:500 dilution) performed on
20 mg total EC lysates from HMEC-1 transfected with control
plasmid (Control) or antisense against Hox B3 (AS) and reveals
a marked reduction in expression of the z28-kD ephrin A1 pro-
tein. B, Northern blot analysis using 10 mg total RNA isolated
from control transfected HMEC-1 (Control) or HMEC-1 trans-
fected with antisense against Hox B3 (AS). The upper panel
shows reduced levels of ephrin A1 mRNA in AS as compared
with control cells. The middle and lower panels show the same
blot reprobed with cDNAs corresponding to either ephrin B1 or
integrin  b3, respectively. The bottom panel shows the corre-
sponding rRNA loading controls.
Figure 4. Addition of recombinant ephrin A1/Fc fusion protein helps restore BM-induced capillary morphology in EC lacking Hox B3.
A, Immunoprecipitation of EphA2 from 300 mg of protein lysates from HMEC-1 transfected with empty vector (Control) or antisense
against Hox B3 (AS) and treated with 250 ng/ml of preclustered ephrin A1 for 20 min. Subsequent blotting with a 1:500 dilution of the
polyclonal antibody against EphA2 reveals similar amounts of the 120-kD ephA2 receptor recovered after immunoprecipitation and
separation by SDS-PAGE on 7.5% acrylamide gels. B, Duplicate samples from control or Hox B3 antisense transfected cells (AS) with
or without the addition of 250 ng/ml of preclustered recombinant ephrin A1 (1ephrinA1) were immunoprecipitated using the anti-
EphA2 antibody and separated by SDS-PAGE and blotted with a 1:1,000 dilution of an mAb against phosphotyrosine (anti-PO4 tyr).
Both control and Hox B3 AS transfected cells showed a significant increase in levels of phosphotyrosine in the 120-kD band corre-
sponding to immunoprecipitated EphA2. C, Shows morphology of control transfected HMEC-1 (Control), HMEC-1 transfected with
antisense against Hox B3 (AS), or antisense cells treated with 250 ng/ml of clustered ephrin A1 (AS 1ephrinA1) 18 h after plating of
0.5 3 106 cells in 60-mm culture dishes coated with 400 ml of BM (Matrigel). 
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High Levels of Hox B3 Promote Angiogenesis In Vivo
 
Based on the above results, we predicted that constitutive
overexpression of Hox B3 in vivo would yield a phenotype
that would be distinct from the hemangiomas that arise in
response to constitutive expression of Hox D3. In addi-
tion, based on our observations that Hox B3 was required
for EC to acquire a tubular three-dimensional capillary
morphology, we also reasoned that constitutive expression
of Hox B3 in vivo may promote capillary morphogenesis
of invasive vascular sprouts induced in response to an an-
giogenic stimuli. To this end, we induced 10-d-old chick
CAMs to undergo angiogenesis by grafting tumorigenic vi-
ral packaging cells onto the CAM. The packaging cells
were transfected with either empty proviral vector (CK)
or retrovirus expressing human Hox B3. After 72 h, we ob-
served that CAMs infected with retrovirus expressing Hox
B3 displayed a significant increase in vascular density and
capillary branching, as compared with CAMs infected
with empty virus (18 
 
6 
 
6.5 branch points/6 mm
 
2
 
 vs. 9.33 
 
6
 
3.78 branch points/6 mm
 
2
 
; 
 
n
 
 5 
 
12,
 
 P , 0.05; Fig. 6). Similar
increases in capillary branching/vascular density was ob-
served in at least 24 different embryonic membranes ex-
amined from four different experiments. Furthermore, we
did not observe any evidence of hemangioma-like struc-
tures characteristic of EC constitutively expressing Hox
D3 (Boudreau et al., 1997). Thus, both in culture and in
vivo, Hox D3 and Hox B3 appear to differentially influ-
ence endothelial gene expression and angiogenesis (Table I).
Finally, to demonstrate that the increase in angiogenic
activity induced in the CAM was related to the presence of
the retrovirally transduced Hox B3, we generated a repli-
cation defective retroviral vector expressing Hox B3 fused
to a 63His epitope tag on the COOH terminus. Similar to
the results seen with the nontagged Hox B3, infection with
the His-tagged Hox B3 also produced increase in endothe-
lial cell density and capillary branches in CAMs after 72 h.
Staining of serial 7-mm sections showed that the increased
endothelial cell density, indicated by positive staining with
von Willebrand factor, colocalized with staining for the His
epitope present in the virally expressed Hox B3 (Fig. 7).
Discussion
We have shown that the Homeobox gene, Hox B3, which
is expressed by HMEC-1, helps promote capillary mor-
phogenesis in culture and angiogenesis in vivo. Further-
more, Hox B3 influences angiogenesis in a manner that is
distinct from the previously described proangiogenic ef-
fects of the paralogous gene, Hox D3 (Boudreau et al.,
1997). Specifically, whereas Hox D3 upregulated expres-
sion of both uPA and integrin avb3, which in turn facili-
tate endothelial cell migration, adhesion, and invasion,
Hox B3 induced expression of ephrin A1 and promoted
capillary morphogenesis of sprouting EC. Furthermore,
this phenotype was reiterated in vivo as Hox B3 promoted
branching and angiogenic behavior, in contrast to the he-
mangioma-like structures generated by Hox D3 (Bou-
dreau et al., 1997). Together, these findings support earlier
observations made in mice lacking two or more paralo-
gous Hox genes, which suggested that, although individual
Hox genes performed distinct functions in a given tissue
type, together, paralogous Hox genes acted in concert to
more dramatically influence overall tissue phenotype and
morphology (Condie and Capecchi, 1994; Manley and
Capecchi, 1997; Chen and Capecchi, 1999).
The requirement for Hox B3 during BM-induced capil-
Figure 5. Overexpression of Hox B3, but not Hox D3, enhances
expression of ephrin A1 in HMEC-1. A, Comparison of HMEC-1
transfected with empty vector (Control) or CMV-driven Hox B3
expression plasmids (Hox B3). Western blots for expression of
Hox B3 (top) and ephrin A1 (bottom) from 40 mg total protein
lysates from control transfected HMEC-1 or those overexpress-
ing Hox B3. B, Immunoprecipitation of 300 mg of lysates from
control of Hox B3 transfected cells using an ephA2 antibody
yields similar levels of the ephA2 receptor (top), whereas subse-
quent blotting with an antiphosphotyrosine antibody shows an
increased degree of phosphorylation of the receptor in cells over-
expressing Hox B3 (bottom). C, Northern blot analysis of ephrin
A1 mRNA levels (top) from 10 mg total RNA isolated from
HMEC-1 transfected with either Hox B3 (Hox B3), or with
empty vector (Control). Lower panel shows corresponding ribo-
somal RNA (rRNA) loading control for each cell type. D, North-
ern blot analysis for b3 integrin and ephrin A1 mRNA levels in
10 mg total RNA isolated from in HMEC-1 transfected with
CMV-driven Hox D3 expression plasmids (Hox D3) or empty
vector (Control). Lower panel shows corresponding levels of
ribosomal RNA (rRNA) visualized with ethidium bromide. E,
The influence of Hox gene expression on EC migration. Migra-
tion of HMEC-1 transfected with control plasmid (h), Hox B3
(j), or Hox D3 ( ) was assessed after 5 h in modified Boyden
chambers coated with 20 mg/ml fibrinogen. Data are expressed as
the mean 6 SD (n 5 3). **P , 0.05.Myers et al. Hox B3 and Angiogenesis 349
lary morphogenesis appears to stem in large part from reg-
ulation of the expression of the ephrin A1 ligand. Al-
though previous studies have linked both Hox A1 and
Hox B1 to expression of the ephA2 receptor (Chen and
Ruley, 1998; Studer et al., 1998), this is the first report that
expression of the ephrin ligands may also be regulated by
homeobox genes. It is of interest to note, however, that an-
other ephrin ligand, ephrin B1 (Lerk 2), was identified
previously in a screen for retinoic acid-inducible genes
(Bouillet et al., 1995), as retinoic acid is amongst the most
potent inducers of anterior class I Homeobox genes
known (Langston and Gudas, 1994).
Recent work has established morphoregulatory roles for
the large family of ephrin ligands and their tyrosine kinase
Eph receptors in both neural pathfinding and vascular de-
velopment, and angiogenesis (for review see Holder and
Klein, 1999). In cultured adult EC, the type of ephrin
ligand required for BM-induced capillary morphogenesis
depends upon the vascular site of origin of the EC. For ex-
ample, branching morphology in renal microvascular cells
requires ephrin B1, whereas capillary morphogenesis of
umbilical vein EC depended on the addition of ephrin A1
(Daniel et al., 1996). Our results using EC derived from
the dermal microvasculature indicate that ephrin A1 is a
potent mediator of capillary morphogenesis in EC derived
from this tissue.
Although interaction with, and subsequent phosphory-
lation of, a corresponding Eph receptor are required for
the morphological effects induced by ephrins, it is not
clear whether these interactions enhance EC migration or
adhesion, or alternatively induce cellular repulsion (and
perhaps promote branching of vascular sprouts), as has
been observed with cultured neurons (Wang and Ander-
son, 1997). One recent report also suggested that ephrin
B1 may stimulate migration of renal microvascular EC via
activation of avb3 integrin-mediated attachment (Huynh-
Do et al., 1999). However, as avb3 is not required for ad-
hesion to BM ECM, and blocking avb3 does not influence
BM-induced capillary morphogenesis in culture, it is un-
likely that the ephrin A1-induced morphological changes
we observed arose via activation of avb3. It is intriguing,
however, to consider the possibility that ephrin A1 may
Figure 6. Retrovirally ex-
pressed Hox B3 promotes tu-
mor-induced angiogenesis in
vivo. 5 3 106 quail fibrosar-
coma-derived viral packaging
cells transfected with empty
vector (CK) or viral vectors
expressing Hox B3 were
grafted on 10-d-old CAMs. A
and B, The resulting small tu-
mors and associated vascula-
ture in the CAMs in response
to grafting 5 3 106 quail fib-
rosarcoma cells producing
empty replication-defective
retroviruses (CK). C and D,
Increased vascular density as-
sociated with tumors pro-
duced on the CAM in re-
sponse to addition of 5 3 106
quail fibrosarcoma cells pro-
ducing replication-defective
retroviruses expressing Hox
B3 (CKHoxB3). The arrows
show areas of angiogenic
sprouting from larger vessels
observed primarily in CAMs
infected with retrovirus ex-
pressing Hox B3.
Table I. Effects of Hox B3 or Hox D3 on EC Behavior
Hox B3 Hox D3
Exposure to bFGF No change in Hox B3 expression Upregulates Hox D3
Culture on BM Increased Hox B3 expression Hox D3 expression suppressed
b3 Integrin mRNA levels Unchanged by overexpression of Hox B3 Upregulated by Hox D3
Ephrin A1 mRNA levels Upregulated by Hox B3 Unchanged by Hox D3
Migration on fibrinogen No effect Enhanced
BM-induced capillary morphogenesis Hox B3 required Not required
Overexpression in vivo Increased angiogenesis Hemangioma hemorrhagic lesionsThe Journal of Cell Biology, Volume 148, 2000 350
activate integrins that mediate EC adhesion to laminin,
the major component of BMs required for capillary mor-
phogenesis (Kubota et al., 1988).
Our results suggest that, in addition to ephrin A1, Hox
B3 may also induce expression of other genes that pro-
mote capillary morphogenesis. For example, although ad-
dition of recombinant ephrin A1 helped restore normal
capillary-like morphology in many of the EC lacking Hox
B3, a small proportion of cells consistently remained in
clusters and failed to elongate or form tubules, despite the
intense phosphorylation of the ephA2 receptor that fol-
lowed addition of ephrin A1. Although the incomplete re-
sponsiveness to exogenous ephrin A1 may be attributed to
heterogeneity amongst the EC population, it is also worth
noting that since Hox genes are considered to be master
regulatory mediators (Botas, 1993; Duboule, 1998), ex-
pression of several, different morphoregulatory genes may
be regulated by Hox B3 in EC. Our preliminary results in-
dicate that EC lacking Hox B3 also show decreased ex-
pression of laminin b2 (LAMB2; data not shown). A role
for this laminin isoform in BM-induced capillary morpho-
genesis is currently under investigation.
Other potential targets of Hox B3 include the thyroid
transcription factor, TTF-1. Studies in HeLa and NIH 3T3
cells showed that TTF-1 expression was specifically acti-
vated by Hox B3, but not the paralogous Hox D3 (Guazzi
et al., 1994). Whether TTF-1 is also a target of Hox B3 in
EC is not known. Studies that examined the effects of Hox
B3 during hematopoietic differentiation indicated that
Hox B3 can exhibit distinct effects on different cell popu-
lations. For example, whereas overexpression of Hox B3
impaired differentiation of B cells, it also promoted expan-
sion of a subset of granulocyte/macrophage cells (Sav-
ageau et al., 1997). Thus, the Hox genes may exert
tissue-specific influences on gene expression. Indeed, our
previous work using Hox D3 expressing retrovirus indi-
cated that upregulation of avb3 integrin was restricted to
endothelial and blood cells, as infected epithelial and fi-
broblast cells did not express avb3 (Boudreau et al., 1997).
Although compound mutants of the Hox 3 paralogous
group have also been generated, the embryonic lethal phe-
notype makes it impossible to study the contribution of
these genes to EC-specific gene expression or angiogene-
sis in adult organisms (Manley and Capecchi, 1997). Fur-
thermore, as evidence from compound mutants for Hox 9
members indicates, embryonic and adult tissues are differ-
entially effected by the same Hox genes (Chen and Capec-
chi, 1999) and embryonic and adult angiogenesis may be
subject to different modes of regulation (Bader et al.,
1998). These genetic models may not help clarify the role
of Hox genes in pathologically induced angiogenesis in dif-
ferentiated adult EC.
Nonetheless, our findings suggest that the multistep pro-
cess of neovascularization requires participation from at
least two paralogous members of the Hox 3 gene family.
Whereas Hox D3 is necessary to initiate vascular sprout-
ing and migration in response to angiogenic stimuli such as
bFGF, Hox B3 is subsequently required by sprouting EC
Figure 7. Increased capillary density correlates retrovirally expressed Hox B3. Immunofluorescence staining of serial 7-mM sections of
CAMs harvested 72 h after application of fibrosarcoma cells producing empty retrovirus (CK) or retrovirus expressing Hox B3 with a
His-6 epitope tag fused to the COOH terminus (1Hox B3). Staining with an antibody against von Willebrand factor (A and D) shows a
relative increase in endothelial cell density in membranes exposed to Hox B3. Staining of serial sections with an antibody against the
63His epitope tag fused to Hox B3 (B and D) reveals positive staining (arrows) in areas associated with increased vascular density. Ar-
eas showing strong autofluorescence within the tumor cores are indicated by the letter t. Corresponding DAPI nuclear staining is shown
for both tissues (C and E).Myers et al. Hox B3 and Angiogenesis 351
to undergo capillary morphogenesis. Whether the com-
bined expression of Hox D3 and Hox B3 will also reveal
additional synergistic interactions is currently not known,
but is the subject of current investigations in our labora-
tory.
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